Clinical Trial Update: A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 study comparing etrolizumab to infliximab in adults with moderate to severe ulcerative colitis who did not receive TNF inhibitors; trial completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrolizumab (etrolizumab)
• Infliximab (infliximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-08-13